Considering all the studies published by numerous authors in murine models as well as in clinical studies, PD-L1 expression on different non-tumor cell types, including several immune cell subsets, conditions the availability of T cells with effector activities that can respond to stimulation by ICIs. This evidence concerns the gene CD274 and neoplasm.